New and emerging oral therapies for psoriasis

New and emerging oral therapies for psoriasis

Psoriasis is a chronic inflammatory skin disease affecting 2–3% of the global population. Traditional systemic treatments, such as methotrexate, cyclosporine, acitretin and fumaric acid esters, have limited efficacy and are associated with significant adverse effects, necessitating regular monitorin...

Full description

Bibliographic Details
Main Authors: Orhan Yilmaz, João Pedro Pinto, Tiago Torres
Format: Article
Language:English
Published: BioExcel Publishing Ltd 2024-08-01
Series:Drugs in Context
Subjects:
a3ar agonists
chronic inflammatory disease
il-17 inhibitors
il-23 inhibitors
oral microbiome
oral therapy
pde4 inhibitors
psoriasis
s1pr1 modulators
small molecules
tnf inhibitors
tyk2 inhibitors
Online Access:https://www.drugsincontext.com/new-and-emerging-oral-therapies-for-psoriasis/

Internet

https://www.drugsincontext.com/new-and-emerging-oral-therapies-for-psoriasis/

Similar Items